News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC
Andy Hahn/X
Jun 2, 2025, 12:04

Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC

Andy Hahn, Genitourinary Medical Oncologist at MD Anderson Cancer Centre, shared a post on X:

“Deep, multi-omic analysis of adjuvant atezolizumab for ccRCC by Sumanta K. Pal and team building on prior KIM-1 studies.
One take away is KIM-1 high, Teff high has longer DFS with atezo than placebo.”

Andy Hahn highlighted new findings from Sumanta K. Pal’s team, showing that patients with high KIM-1 and Teff expression experienced longer disease-free survival when treated with atezolizumab in adjuvant clear cell renal cell carcinoma.

Andy Hahn: Deep, Multi-Omic Analysis of Adjuvant Atezolizumab for ccRCC

More posts featuring Andy Hahn.

Andy Hahn atezolizumab cancer ccRCC DFS fight against cancer Global fight against cancer KIM-1 studies OncoDaily Oncology Sumanta K. Pal
Special Coverage
Oncolibrary
Jun 25, 2025, 10:27
The Day After a Nuclear Bomb: Generational Damage and the Silent Cancer Epidemic
Blog
Jun 25, 2025, 10:00
Scientific Advisory Board Members - World Bladder Cancer Patient Coalition
Science
Jun 25, 2025, 09:58
Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab
Insight
Jun 25, 2025, 09:52
Shruti Patel: Who Decides Who Decides?
Blog
Jun 25, 2025, 09:42
Krishna Soujanya Gunturu Co-Leads a Reopened S2013 ICHECKIT Cancer Trial - SWOG Cancer Research Network
Science
Jun 25, 2025, 09:39
Chad Pecot: A First-in-Class EGFR-Directed KRAS G12V Selective Inhibitor
Science
Jun 25, 2025, 09:27
Mario Balsa: Real-world Comparison in Advanced HCC - Atezolizumab + Bevacizumab vs Tremelimumab + Durvalumab
Blog
Jun 25, 2025, 09:08
Laura Bukavina: How Do We Predict Patients with True CR Using Urine Biomarkers?
Science
Jun 25, 2025, 09:08
Myeloma Paper of the Day, June 25th, suggested by Robert Orlowski
Blog
Jun 25, 2025, 09:07
Mikkael Sekeres: Can BPAs, PFAS, or Phthalates in Everyday Household Items Can Cause Cancer?
Insight
Jun 25, 2025, 09:00
Stephen V Liu on Phase 2 Study of Irinotecan plus Anlotinib for Platinum-Resistant SCLC
Insight
Jun 25, 2025, 08:59
David Tougeron Shared Study on Prognostic Tool for Third-Line Chemotherapy in Unresectable Pancreatic Cancer